Radiopharmaceuticals for Diagnostics and Therapy of Neuroendocrine Tumors

Authors

  • P. Švec Institute of Macromolecular Chemistry, AS CR, v.v.i., Prague
  • M. Hrubý Institute of Macromolecular Chemistry, AS CR, v.v.i., Prague

Keywords:

neuroendocrine tumors, radiopharmaceuticals, somatostatin, fluorodeoxyglucose, m-iodobenzylguanidine, fluorodihydroxyphenylalanine, 5-hydroxytryptophan, exendin

Abstract

This article provides a general overview of radiopharmaceuticals for diagnostics and therapy of neuroendocrine tumors. These agents employ specific differences between neuroendocrine tumors and normal tissues on the cellular level. Individual radiopharmaceuticals demonstrate examples of typical strategies for targeted radionuclide accumulation in tumor cells.

Downloads

Published

2017-01-15

How to Cite

Švec, P., & Hrubý, M. (2017). Radiopharmaceuticals for Diagnostics and Therapy of Neuroendocrine Tumors. Chemické Listy, 111(1), 3–10. Retrieved from http://ww.w.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/105

Issue

Vol. 111 No. 1 (2017)

Section

Articles

Most read articles by the same author(s)

1 2 > >>